Stockreport

Kymera Therapeutics to Participate in Upcoming September Investor Conferences

Kymera Therapeutics, Inc.  (KYMR) 
PDF WATERTOWN, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small [Read more]